Quarterly Journal of Nuclear Medicine and Molecular Imaging

Papers
(The median citation count of Quarterly Journal of Nuclear Medicine and Molecular Imaging is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Immunoscore and its introduction in clinical practice44
The LIPI score and inflammatory biomarkers for selection of patients with solid tumors treated with checkpoint inhibitors33
Choline PET/CT features to predict survival outcome in high-risk prostate cancer restaging: a preliminary machine-learning radiomics study11
Is 99mTc-HMPAO-leukocyte imaging an accurate method in evaluating therapy result in prosthetic joint infection and diagnosing suspected chronic prosthetic joint infection?11
The emerging value of 64Cu for molecular imaging and therapy11
Differential diagnostic ability of 18F-FDG PET/CT radiomics features between renal cell carcinoma and renal lymphoma11
Volumetric 68Ga-DOTA-TATE PET/CT for assessment of whole-body tumor burden as a quantitative imaging biomarker in patients with metastatic gastroenteropancreatic neuroendocrine tumors10
Copper-64 based radiopharmaceuticals for brain tumors and hypoxia imaging9
Lung shunt and lung dose calculation methods for radioembolization treatment planning9
Prognostic importance of prostatic specific antigen response in patients who received Lutetium-177 prostate-specific membrane antigen treatment for castration resistant prostate cancer9
Current and novel radiopharmaceuticals for imaging cardiovascular inflammation9
Optimal use of [18F]FDG-PET/CT in patients with fever or inflammation of unknown origin8
Evaluation of physiologic and abnormal glucose uptake in palatine tonsils: differential diagnostics with sequential dual-time-point 2-deoxy-2-[18F]FDG PET/CT8
Practice and prospects for PET/CT guided interventions8
Nuclear medicine radiomics in precision medicine: why we can't do without artificial intelligence8
Applicability of sentinel lymph node biopsy in papillary thyroid cancer8
Fully integrated [18F]FDG PET/MR in large vessel vasculitis7
Reduction of emission time for [68Ga]Ga-PSMA PET/CT using the digital biograph vision: a phantom study7
Adverse effects under immune checkpoint inhibitors on [18F]FDG PET/CT imaging7
Beta radioguided surgery: towards routine implementation?6
Interventional nuclear medicine: a focus on radioguided intervention and surgery6
PSMA uptake on [68Ga]-PSMA-11-PET/CT positively correlates with prostate cancer aggressiveness6
The role of PET imaging in inflammatory bowel diseases: state-of-the-art review6
IAEA contribution to the development of 64Cu radiopharmaceuticals for theranostic applications6
Update on tumor metabolism and patterns of response to immunotherapy6
Molecular imaging of endocrine neoplasms with emphasis on 18F-DOPA PET: a practical approach for well-tailored imaging protocols5
Diagnostic value of positron-emission tomography textural indices for malignancy of 18F-fluorodeoxyglucose-avid adrenal lesions5
Copper, PET/CT and prostate cancer: a systematic review of the literature5
Functional and molecular thyroid imaging5
Comparison of visual criteria for amyloid-PET reading: could criteria merging reduce inter-rater variability?4
Radioiodine therapy of thyroid autonomy4
[18F]F-Choline PET/CT and 4D-CT in the evaluation of primary hyperparathyroidism: rivals or allies?4
Dosimetry of nuclear medicine therapies: current controversies and impact on treatment optimization4
The role of laboratory medicine in the diagnosis of the hyperthyroidism4
An essential practice summary of the new EANM guidelines for parathyroid imaging4
PET- and SPECT-based navigation strategies to advance procedural accuracy in interventional radiology and image-guided surgery4
Targeted alpha therapy: a critical review of translational dosimetry research with emphasis on actinium-2254
Radioiodine therapy of Graves' disease4
Theragnostic radionuclides: a clinical perspective4
Therapeutic applications of radioactive sources: from image-guided brachytherapy to radio-guided surgical resection4
Update on diagnosis and treatment of hyperthyroidism: ultrasonography and functional imaging4
Integration of molecular imaging in the personalized approach of patients with adrenal masses4
Copper-64 labeled nanoparticles for positron emission tomography imaging: a review of the recent literature4
Molecular imaging of norepinephrine transporter-expressing tumors: current status and future prospects3
Predictive factors of preoperative sentinel lymph node detection in intermediate and high-risk endometrial cancer3
Imaging inflammation in cardiovascular disease: translational perspective and overview3
Detection rate of 18F-Choline positron emission tomography/computed tomography in patients with non-metastatic hormone sensitive and castrate resistant prostate cancer3
Graves' orbitopathy: a multidisciplinary approach3
18F-FDG PET/CT concurrent with first radioiodine post-therapeutic scan in high risk differentiated thyroid cancer: a useful tool or just an expensive diversion?3
Managing radioiodine refractory thyroid cancer: the role of dosimetry and redifferentiation on subsequent I-131 therapy3
Prognostic value and optimal threshold of first thyroglobulin in low/intermediate risk DTC3
Clinical value of [18F]FDG-PET/CT and 3D-black-blood 3T-MRI for the diagnosis of large vessel vasculitis and single-organ vasculitis of the aorta3
Radiosynoviorthesis: almost seventy years of experience but still somewhat fameless3
Prognostic and predictive role of the tumor immune landscape3
The role of PET/CT in large vessel vasculitis and related disorders: diagnosis, extent evaluation and assessment of therapy response3
Correlation study on 18F-FDG PET/CT metabolic characteristics of primary lesion with clinical stage in lung cancer2
Medical treatment of thyrotoxicosis2
Is there a glucose metabolic signature of spreading TDP-43 pathology in amyotrophic lateral sclerosis?2
The role of PET/CT in thyroid autoimmune diseases2
Multiple endocrine neoplasia type 1 or 4: detection of hyperfunctioning parathyroid glands with 18F-fluorocholine PET/CT. Illustrative cases and pitfalls2
Adding 64Cu radiopharmaceuticals to the toolkit of molecular imaging2
The role of [18F]FDG PET/CT in paraneoplastic autoimmune disorders: an umbrella review2
Detection, resection and cure: a systematic review and meta-analysis of 18F-choline PET in primary hyperparathyroidism2
Prognostic value of metabolic parameters on baseline 18F-FDG PET/CT in small cell lung cancer2
Theragnostic in neuroendocrine tumors2
Contemporary update of SPECT tracers and novelties in radioguided surgery: a perspective based on urology2
Theragnostics applications and challenges2
Imaging inflammation after myocardial infarction: implications for prognosis and therapeutic guidance2
Bone health evaluation in primary hyperparathyroidism using dual-energy X-ray absorptiometry and trabecular bone score2
Imaging of dopamine transporter with [18F]LBT-999: initial evaluation in healthy volunteers2
Is 18F-fluorodeoxyglucose positron emission tomography/computed tomography useful to discriminate metachronous lung cancer from metastasis in patients with oncological history?2
The sentinel node with technetium-99m for prostate cancer. A safe and mature new gold standard?2
Predictor of 68Ga PSMA PET/CT positivity in patients with prostate cancer2
Positron emission tomography-magnetic resonance imaging as a research tool in musculoskeletal conditions2
Changes over the years in radiopharmaceutical design2
[68Ga]DOTA-TATE PET for the detection of early transplant rejection in a heterotopic allograft heart transplantation model of the rat: a pilot study2
Current approach to surgical management of hyperthyroidism2
Concomitant semi-quantitative and visual analysis improves the predictive value on treatment outcome of interim 18F-fluorodeoxyglucose/positron-emission tomography in advanced Hodgkin lymphoma2
Uptake pattern of [68Ga]Ga-DOTA-NOC in tissues: implications for inflammatory diseases2
Extremity exposure of nuclear medicine workers: results from an EANM and EURADOS survey2
Theragnostics in primary and secondary liver tumors: the need for a personalized approach2
Copper-64-immunoPET imaging: bench to bedside1
Application of a smart 18F-FDG-PET adaptive threshold segmentation algorithm for the biological target volume delineation in head and neck cancer1
Radiation protection aspects for alpha therapies1
Respiratory gated multistatic PET reconstructions to delineate radiotherapy target volume in patients with mobile lung tumors1
Image-guided surgery: from classical techniques to novel aspects and approaches1
The effect of chewing-gum on dose rate of salivary gland in differentiated thyroid carcinoma patients treated with radioiodine1
F18-FET PET in pediatric brain tumors: integrative analysis of image derived parameters and clinico-pathological data1
Innovations in imaging modalities: a comparative review of MRI, long-axial field-of-view PET, and full-ring CZT-SPECT in detecting bone metastases1
Main challenges in radiation protection with emerging radionuclide therapies1
[18F]FDG PET/CT in rheumatoid arthritis1
Role of 18F-NaF PET/CT in bone metastases1
Theragnostics in prostate cancer1
82Rubidium chloride positron emission tomography discrimination of recurrent intracranial malignancy from radiation necrosis1
Cancer management in the era of immunotherapy: much more than meets the eye1
Inflammation imaging to define vulnerable plaque or vulnerable patient1
Improved automated synthesis of [18F]FINH-Me via direct radio-fluorination and quality control for Aβ-amyloid imaging1
Practical setting and potential applications of interventions guided by PET/MRI1
Comparison of post-therapeutic sequential 131I whole-body scans in the detection of metastatic thyroid cancer1
Comparison of different motion correction techniques for dynamic FDG-PET/CT studies in breast cancer patients1
The role of PET/CT in connective tissue disorders: systemic sclerosis, Sjögren's syndrome and systemic lupus erythematosus1
Side effects of theragnostic agents currently employed in clinical practice1
Dual-tracer 99mTc-sestamibi/ 123I imaging in primary hyperparathyroidism1
Imaging cardiac sarcoidosis and infiltrative diseases: diagnosis and therapeutic response1
Challenges in theragnostics1
18F-FDG-PET/CT imaging of uterine cervical cancer recurrence in women with and without HIV infection1
Prognostic importance of SUVmax values evaluated by 18F-FDG-PET/CT before nivolumab treatment in patients with metastatic renal cell carcinoma1
Contribution of positron emission tomography/magnetic resonance imaging in musculoskeletal malignancies1
Correlation of 18F-FDG uptake and thyroid cancer stem cells1
The role of fluorescent and hybrid tracers in radioguided surgery in urogenital malignancies1
Perceptual omission errors in positron emission tomography and computed tomography reporting1
Preclinical imaging for targeting cancer immune evasion1
Role of 18F-FDG-PET/CT in assessment of pediatric Hodgkin's lymphoma1
18F-fluorocholine PET/CT detects parathyroid gland hyperplasia as well as adenoma: 401 PET/CTs in one center1
0.037870168685913